Literature DB >> 9810264

Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells.

E A Mazzio1, N Harris, K F Soliman.   

Abstract

Glial cell monoamine oxidase (MAO) activity has been implicated as a contributor to oxidative neuronal damage associated with various neurodegenerative diseases. The attenuation of MAO activity may provide protection against oxidative neurodegeneration. In this investigation, the presence of MAO-B in rat C6 astrocyte cells was substantiated by dose-dependent inhibition of enzyme activity in the presence of chlorgyline-HCl and L-deprenyl. The present study evaluated various dietary-derived food constituents for evidence of inhibition on oxidative deamination of monoamines or peroxide radical trapping capacity. Results of this investigation indicate that compounds which inhibit C6 glial cell MAO enzyme activity or scavenge peroxide product include chlorogenic acid, (+)-catechin, taxifolin, (-)-epigallocatechin gallate (EGCG), fisetin, coenzyme Q0, curcumin, sesamol, morin, sesame oil, silymarin, green tea, ferulic acid, caffeic acid, and rutin hydrate. The results of this study indicate that dietary compounds can attenuate peroxide production in glial cells by either inhibiting the deamination of monoamines or acting as a free radical scavenger.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810264     DOI: 10.1055/s-2006-957530

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  21 in total

1.  Acidic vesicles of the endo-exocytic pathways as targets for some anti-monoamine oxidase drugs.

Authors:  Paolo Dell'Antone; Meryem IbnLkayat; Denise Drago; Paolo Zatta
Journal:  Metab Brain Dis       Date:  2007-07-12       Impact factor: 3.584

Review 2.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

3.  Milk Thistle Treatment for Children and Adults with Trichotillomania: A Double-Blind, Placebo-Controlled, Crossover Negative Study.

Authors:  Jon E Grant; Sarah A Redden; Samuel R Chamberlain
Journal:  J Clin Psychopharmacol       Date:  2019 Mar/Apr       Impact factor: 3.153

4.  Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction.

Authors:  Reyna L VanGilder; Jason D Huber
Journal:  Postdoc J       Date:  2014-07

5.  Antidepressant activity of phytochemicals of Mangifera indica seeds assisted by integrated computational analysis.

Authors:  Uzma Saleem; Shafa Iman; Bashir Ahmad; Muhammad Ajmal Shah; Shabana Bibi; Mohammed Alqarni; Muhammad Saad Khan; Ghulam Mujtaba Shah; Haroon Khan; Reem Hasaballah Alhasani; Norah A Althobaiti; Aishah E Albalawi
Journal:  Metab Brain Dis       Date:  2022-03-28       Impact factor: 3.584

Review 6.  Selective MAO-B inhibitors: a lesson from natural products.

Authors:  Simone Carradori; Melissa D'Ascenzio; Paola Chimenti; Daniela Secci; Adriana Bolasco
Journal:  Mol Divers       Date:  2013-11-12       Impact factor: 2.943

7.  High throughput screening to identify natural human monoamine oxidase B inhibitors.

Authors:  E Mazzio; S Deiab; K Park; K F A Soliman
Journal:  Phytother Res       Date:  2012-08-08       Impact factor: 5.878

8.  Piperine potentiates the effects of trans-resveratrol on stress-induced depressive-like behavior: involvement of monoaminergic system and cAMP-dependent pathway.

Authors:  Ying Xu; Chong Zhang; Feiyan Wu; Xiaoxiao Xu; Gang Wang; Mengmeng Lin; Yingcong Yu; Yiran An; Jianchun Pan
Journal:  Metab Brain Dis       Date:  2016-03-05       Impact factor: 3.584

9.  Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system.

Authors:  Russell L Blaylock; Joseph Maroon
Journal:  Surg Neurol Int       Date:  2012-02-15

10.  Antidepressant activity of curcumin: involvement of serotonin and dopamine system.

Authors:  Shrinivas K Kulkarni; Mohit Kumar Bhutani; Mahendra Bishnoi
Journal:  Psychopharmacology (Berl)       Date:  2008-09-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.